MM+M Awards 2022 finalists revealed
Medical marketing’s biggest night is set for October 6 with a live gala at Cipriani Wall Street that will be streamed online.
Source: mmm-online.com
Page 6 - Urovant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Urovant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Urovant Sciences Today - Breaking & Trending Today
Urovant Sciences, Inc.: The Impact of Urinary Incontinence Related to Overactive Bladder on Long-Term Care Residents and Facilities in the U.S. Highlighted in New Survey
Survey of 71 Directors of Nursing (DONs) highlights a need for improved awareness, education, and management of urinary incontinence (UI) related to overactive bladder (OAB) in long-term care (LTC)
Source: finanznachrichten.de
The Impact of Urinary Incontinence Related to Overactive Bladder on Long-Term Care Residents and Facilities in the U.S. Highlighted in New Survey
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Urovant Sciences, Inc.: Urovant Sciences Named One of 2022 Best Places to Work in Orange County
This is Urovant's second year in a row to earn this recognition by Orange County Business Journal Urovant has also received a 2022 global Great Place to Work certification. The culmination
Source: finanznachrichten.de
Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland
Pierre Fabre Médicament SAS (Pierre Fabre) to register and commercialize vibegron for the treatment of Overactive Bladder (OAB) in the Europe Economic Area, UK, and Switzerland. Urovant Sciences
Source: finanznachrichten.de